A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited settingRenxian Xie, Chuangzhen Chen, Y. Ji et al.|PLoS ONE|2025Cited by 2
Immunotherapy-related cardiovascular toxicity: from mechanisms to managementLifeng Xiao, Renxian Xie, Y. Ji et al.|Frontiers in Pharmacology|2026Cited by 0